Fertility and Sterility, 80(5), 1302-1308, 2003

Use of clomiphene citrate in women

Practice Committee of the American Society for Reproductive Medicine , The Practice Committee of the American Society for Reproductive Medicine , American Society for Reproductive Medicine

Author affiliations
  • American Society for Reproductive Medicine ROR
DOI10.1016/s0015-0282(03)01184-1 PMID14607612
Read at publisher

Abstract not indexed. Read at publisher

Topics

clomiphene citrate use women ASRM guidelines, clomiphene citrate ovulation induction protocol, clomid treatment anovulation infertility, clomiphene citrate indications dosing women, ASRM practice committee clomiphene citrate, selective estrogen receptor modulator ovulation induction, clomiphene citrate unexplained infertility, clomid side effects risks monitoring, clomiphene citrate PCOS anovulatory infertility, first line ovulation induction clomiphene
PMID 14607612 14607612 DOI 10.1016/s0015-0282(03)01184-1 10.1016/s0015-0282(03)01184-1

Cite this article

Practice Committee of the American Society for Reproductive Medicine (2003). Use of clomiphene citrate in women. *Fertility and Sterility*, *80*(5), 1302-1308. https://doi.org/10.1016/s0015-0282(03)01184-1

Related articles